Wen-Ying Jiang, M.D., Zhi-Tian Li, M.D., Zhong Jia*, Ph.D.

ABSTRACT

breast cancer, cervical cancer is the second-most-common cancer in women aged 15 to 44 in China. According to the National Cancer Center, China had 98,900 new emerged cervical cancer patients last year, which accounts for more than 28 percent of the total cases in the world, and about 30,500 people died from the disease. One of the most popular human papilioma virus (HPV) vaccine, Cervarix, is being worldwide used, will hit Chinese mainland market in early 2017.It targets HPV-16 and HPV-18,which is identified as the chief cause of cervical cancer, and is found in majority (84%) of HPV cases in China